Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan · Delayed Price · Currency is JPY 6,040.00
0.00 (0.00%)
May 8, 2026, 3:30 PM JST
TYO:4530 Cash Flow Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Net Income | 23,656 | 28,687 | 19,186 | 16,113 | 12,956 |
Depreciation & Amortization | 7,051 | 6,335 | 5,172 | 4,952 | 4,321 |
Loss (Gain) From Sale of Assets | 63 | 342 | 852 | -319 | 55 |
Loss (Gain) From Sale of Investments | -137 | -5,019 | -389 | 257 | -653 |
Loss (Gain) on Equity Investments | -728 | -590 | -585 | -424 | -569 |
Other Operating Activities | -4,894 | -3,815 | -3,954 | -5,311 | -119 |
Change in Accounts Receivable | -9,177 | -2,525 | -2,082 | 780 | 2,191 |
Change in Inventory | -3,482 | -347 | -1,628 | -1,581 | 3,073 |
Change in Accounts Payable | 2,890 | -2,642 | 686 | 653 | -2,196 |
Change in Other Net Operating Assets | 2,236 | -1,661 | 930 | -2,393 | 140 |
Operating Cash Flow | 17,478 | 18,765 | 18,188 | 12,727 | 19,199 |
Operating Cash Flow Growth | -6.86% | 3.17% | 42.91% | -33.71% | 263.00% |
Capital Expenditures | -7,995 | -13,627 | -12,924 | -7,859 | -3,610 |
Sale of Property, Plant & Equipment | 311 | 154 | 186 | 1,004 | 37 |
Sale (Purchase) of Intangibles | -55 | -147 | -112 | -49 | -583 |
Investment in Securities | -9,127 | 31,181 | 17,109 | -16,966 | -8,918 |
Other Investing Activities | -1 | 1 | -6,773 | - | 12 |
Investing Cash Flow | -16,866 | 17,563 | -2,512 | -23,868 | -13,060 |
Long-Term Debt Issued | - | 1,830 | - | - | - |
Total Debt Issued | - | 1,830 | - | - | - |
Short-Term Debt Repaid | -100 | - | -4 | - | -40 |
Long-Term Debt Repaid | -1,752 | -217 | -66 | -71 | -77 |
Total Debt Repaid | -1,852 | -217 | -70 | -71 | -117 |
Net Debt Issued (Repaid) | -1,852 | 1,613 | -70 | -71 | -117 |
Issuance of Common Stock | 1,766 | - | - | - | - |
Repurchase of Common Stock | -12,273 | -10,554 | -9,796 | -7,694 | -8,043 |
Common Dividends Paid | -7,593 | -6,519 | -6,578 | -6,719 | -6,839 |
Other Financing Activities | -246 | -390 | -247 | -203 | -190 |
Financing Cash Flow | -20,198 | -15,850 | -16,691 | -14,687 | -15,189 |
Foreign Exchange Rate Adjustments | -262 | 2,936 | 1,957 | 5,005 | 3,944 |
Miscellaneous Cash Flow Adjustments | -1 | - | -1 | 1 | - |
Net Cash Flow | -19,849 | 23,414 | 941 | -20,822 | -5,106 |
Free Cash Flow | 9,483 | 5,138 | 5,264 | 4,868 | 15,589 |
Free Cash Flow Growth | 84.57% | -2.39% | 8.13% | -68.77% | 700.26% |
Free Cash Flow Margin | 5.82% | 3.29% | 3.72% | 3.79% | 12.97% |
Free Cash Flow Per Share | 132.75 | 69.70 | 68.36 | 61.30 | 191.82 |
Cash Interest Paid | 21 | 25 | 18 | 15 | 20 |
Cash Income Tax Paid | 5,099 | 4,279 | 4,017 | 5,333 | 505 |
Levered Free Cash Flow | 1,003 | -379.38 | -2,703 | 10,116 | 12,213 |
Unlevered Free Cash Flow | 1,016 | -365 | -2,692 | 10,126 | 12,226 |
Change in Working Capital | -7,533 | -7,175 | -2,094 | -2,541 | 3,208 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.